173 related articles for article (PubMed ID: 10958795)
21. The müllerian inhibitor and mammalian sexual development.
Behringer RR
Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
[TBL] [Abstract][Full Text] [Related]
22. Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer.
Pieretti-Vanmarcke R; Donahoe PK; Pearsall LA; Dinulescu DM; Connolly DC; Halpern EF; Seiden MV; MacLaughlin DT
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17426-31. PubMed ID: 17088539
[TBL] [Abstract][Full Text] [Related]
23. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
Visser JA; Olaso R; Verhoef-Post M; Kramer P; Themmen AP; Ingraham HA
Mol Endocrinol; 2001 Jun; 15(6):936-45. PubMed ID: 11376112
[TBL] [Abstract][Full Text] [Related]
24. The in vivo roles of müllerian-inhibiting substance.
Behringer RR
Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
[TBL] [Abstract][Full Text] [Related]
25. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
[TBL] [Abstract][Full Text] [Related]
26. Mullerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosis.
Namkung J; Song JY; Jo HH; Kim MR; Lew YO; Donahoe PK; MacLaughlin DT; Kim JH
J Clin Endocrinol Metab; 2012 Sep; 97(9):3224-30. PubMed ID: 22761458
[TBL] [Abstract][Full Text] [Related]
27. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
Weniger JP; Cate RL; Zeis A
J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
[TBL] [Abstract][Full Text] [Related]
28. Antibody against avian müllerian inhibiting substance (MIS) recognizes MIS on rat müllerian duct and human tumor cells.
Wang JJ; Teng CS
Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):267-75. PubMed ID: 2484046
[TBL] [Abstract][Full Text] [Related]
29. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats.
Sriraman V; Niu E; Matias JR; Donahoe PK; MacLaughlin DT; Hardy MP; Lee MM
J Androl; 2001; 22(5):750-8. PubMed ID: 11545286
[TBL] [Abstract][Full Text] [Related]
30. Reduction of epidermal growth factor receptor phosphorylation by activated Mullerian inhibiting substance is vanadate-sensitive.
Maggard MA; Catlin EA; Hudson PL; Donahoe PK; MacLaughlin DT
Metabolism; 1996 Feb; 45(2):190-5. PubMed ID: 8596488
[TBL] [Abstract][Full Text] [Related]
31. Regulation of ovarian function: the role of anti-Müllerian hormone.
Durlinger AL; Visser JA; Themmen AP
Reproduction; 2002 Nov; 124(5):601-9. PubMed ID: 12416998
[TBL] [Abstract][Full Text] [Related]
32. Paracrine-mediated apoptosis in reproductive tract development.
Roberts LM; Hirokawa Y; Nachtigal MW; Ingraham HA
Dev Biol; 1999 Apr; 208(1):110-22. PubMed ID: 10075845
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic effects of müllerian inhibiting substance (MIS)?
Janssens JP; Noto V; van Tendeloo G; Bonte J; de Loecker W
Anticancer Res; 1988; 8(4):781-4. PubMed ID: 3178166
[TBL] [Abstract][Full Text] [Related]
34. Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo.
Stephen AE; Masiakos PT; Segev DL; Vacanti JP; Donahoe PK; MacLaughlin DT
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3214-9. PubMed ID: 11248058
[TBL] [Abstract][Full Text] [Related]
35. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.
Lee MM; Seah CC; Masiakos PT; Sottas CM; Preffer FI; Donahoe PK; Maclaughlin DT; Hardy MP
Endocrinology; 1999 Jun; 140(6):2819-27. PubMed ID: 10342873
[TBL] [Abstract][Full Text] [Related]
36. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance.
Behringer RR; Cate RL; Froelick GJ; Palmiter RD; Brinster RL
Nature; 1990 May; 345(6271):167-70. PubMed ID: 2336108
[TBL] [Abstract][Full Text] [Related]
37. Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice.
Donahoe PK; Fuller AF; Scully RE; Guy SR; Budzik GP
Ann Surg; 1981 Oct; 194(4):472-80. PubMed ID: 6895157
[TBL] [Abstract][Full Text] [Related]
38. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.
Teixeira J; Maheswaran S; Donahoe PK
Endocr Rev; 2001 Oct; 22(5):657-74. PubMed ID: 11588147
[TBL] [Abstract][Full Text] [Related]
39. Mullerian inhibiting substance: a fetal hormone with surgical implications.
Hutson JM; Donahoe PK; Budzik GP
Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
[TBL] [Abstract][Full Text] [Related]
40. Anti-Proliferative and Apoptotic Activities of Müllerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell Lines.
Jung YS; Kim HJ; Seo SK; Choi YS; Nam EJ; Kim S; Kim SW; Han HD; Kim JW; Kim YT
Yonsei Med J; 2016 Jan; 57(1):33-40. PubMed ID: 26632380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
